{"transactions":[{"id":1135566,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":79334,"kind":"person","name":"Hashim Mir","position":1,"cik":"0001875891","reported_name":"Hashim Mir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-23T18:48:02.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":325000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from May 23, 2025."}],"balance_after":325000,"derivative":{"exercise_price":0.6168,"expiration_date":"2035-05-22","underlying":"Class A Common Stock","underlying_shares":325000},"source":{"system":"sec-edgar","filing":"0000950170-25-077226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875891/000095017025077226/ownership.xml","form_type":"4"}},{"id":1563603,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":79334,"kind":"person","name":"Hashim Mir","position":1,"cik":"0001875891","reported_name":"Hashim Mir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-22T21:00:15.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":323500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 21, 2024."}],"balance_after":323500,"derivative":{"exercise_price":3.6,"expiration_date":"2034-03-20","underlying":"Class A Common Stock","underlying_shares":323500},"source":{"system":"sec-edgar","filing":"0000950170-24-035571","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875891/000095017024035571/ownership.xml","form_type":"4"}},{"id":1705207,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":79334,"kind":"person","name":"Hashim Mir","position":1,"cik":"0001875891","reported_name":"Hashim Mir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T16:05:35.000Z","date":"2023-12-16","kind":"grant","planned":false,"acquired":true,"shares":83724,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from June 17, 2021."}],"balance_after":83724,"derivative":{"exercise_price":2.84,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":83724},"source":{"system":"sec-edgar","filing":"0000950170-23-071473","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1875891/000095017023071473/ownership.xml","form_type":"4"}},{"id":1705206,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":79334,"kind":"person","name":"Hashim Mir","position":1,"cik":"0001875891","reported_name":"Hashim Mir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T16:05:35.000Z","date":"2023-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":83724,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from June 17, 2021."}],"balance_after":127788,"derivative":{"exercise_price":9.44,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":83724},"source":{"system":"sec-edgar","filing":"0000950170-23-071473","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1875891/000095017023071473/ownership.xml","form_type":"4"}},{"id":1705205,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":79334,"kind":"person","name":"Hashim Mir","position":1,"cik":"0001875891","reported_name":"Hashim Mir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T16:05:35.000Z","date":"2023-12-16","kind":"grant","planned":false,"acquired":true,"shares":73150,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022."}],"balance_after":73150,"derivative":{"exercise_price":2.84,"expiration_date":"2032-03-21","underlying":"Class A Common Stock","underlying_shares":73150},"source":{"system":"sec-edgar","filing":"0000950170-23-071473","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1875891/000095017023071473/ownership.xml","form_type":"4"}},{"id":1705204,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":79334,"kind":"person","name":"Hashim Mir","position":1,"cik":"0001875891","reported_name":"Hashim Mir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T16:05:35.000Z","date":"2023-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":73150,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."}],"balance_after":52250,"derivative":{"exercise_price":13.21,"expiration_date":"2032-03-21","underlying":"Class A Common Stock","underlying_shares":73150},"source":{"system":"sec-edgar","filing":"0000950170-23-071473","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875891/000095017023071473/ownership.xml","form_type":"4"}},{"id":1705203,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":79334,"kind":"person","name":"Hashim Mir","position":1,"cik":"0001875891","reported_name":"Hashim Mir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T16:05:35.000Z","date":"2023-12-16","kind":"grant","planned":false,"acquired":true,"shares":171500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023."}],"balance_after":171500,"derivative":{"exercise_price":2.84,"expiration_date":"2033-03-26","underlying":"Class A Common Stock","underlying_shares":171500},"source":{"system":"sec-edgar","filing":"0000950170-23-071473","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875891/000095017023071473/ownership.xml","form_type":"4"}},{"id":1705202,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":79334,"kind":"person","name":"Hashim Mir","position":1,"cik":"0001875891","reported_name":"Hashim Mir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T16:05:35.000Z","date":"2023-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":171500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."}],"balance_after":34300,"derivative":{"exercise_price":5.44,"expiration_date":"2033-03-26","underlying":"Class A Common Stock","underlying_shares":171500},"source":{"system":"sec-edgar","filing":"0000950170-23-071473","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875891/000095017023071473/ownership.xml","form_type":"4"}},{"id":1935899,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":79334,"kind":"person","name":"Hashim Mir","position":1,"cik":"0001875891","reported_name":"Hashim Mir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-29T21:09:16.000Z","date":"2023-03-27","kind":"grant","planned":false,"acquired":true,"shares":205800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest as follows:  1/48th of the shares subject to the option vest monthly over four years from March 27, 2023."}],"balance_after":205800,"derivative":{"exercise_price":5.44,"expiration_date":"2033-03-26","underlying":"Class A Common Stock","underlying_shares":205800},"source":{"system":"sec-edgar","filing":"0001415889-23-005598","document":"form4-03302023_010306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875891/000141588923005598/form4-03302023_010306.xml","form_type":"4"}},{"id":1935898,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":79334,"kind":"person","name":"Hashim Mir","position":1,"cik":"0001875891","reported_name":"Hashim Mir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2023-03-29T21:09:16.000Z","date":"2023-03-27","kind":"grant","planned":false,"acquired":true,"shares":139000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The shares subject to the restricted stock unit grant vest as follows:  1/16th of the RSUs shall vest quarterly over four years from March 27, 2023."}],"balance_after":273265,"source":{"system":"sec-edgar","filing":"0001415889-23-005598","document":"form4-03302023_010306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875891/000141588923005598/form4-03302023_010306.xml","form_type":"4"}},{"id":1939267,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":79334,"kind":"person","name":"Hashim Mir","position":1,"cik":"0001875891","reported_name":"Hashim Mir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-24T16:05:15.000Z","date":"2023-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":4201,"price":5.95,"value":24995.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by and surrendered to the Issuer on March 22, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the restricted stock units granted to Dr. Hashim on March 22, 2022."}],"balance_after":134265,"source":{"system":"sec-edgar","filing":"0000899243-23-009584","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875891/000089924323009584/doc4.xml","form_type":"4"}},{"id":2160301,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":79334,"kind":"person","name":"Hashim Mir","position":1,"cik":"0001875891","reported_name":"Hashim Mir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-13T20:41:31.000Z","date":"2022-09-09","kind":"tax_withholding","acquired":false,"shares":20334,"price":9.89,"value":201103.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by and surrendered to the Issuer on September 9, 2022, to satisfy tax withholding obligations that arose in connection with the vesting of the restricted stock units granted to Mr. Hashim on September 9, 2021."}],"balance_after":138466,"source":{"system":"sec-edgar","filing":"0001209191-22-049800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875891/000120919122049800/doc4.xml","form_type":"4"}},{"id":2319040,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":79334,"kind":"person","name":"Hashim Mir","position":1,"cik":"0001875891","reported_name":"Hashim Mir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-24T21:06:41.000Z","date":"2022-03-22","kind":"grant","acquired":true,"shares":125400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022."}],"balance_after":125400,"derivative":{"exercise_price":13.21,"expiration_date":"2032-03-21","underlying":"Class A Common Stock","underlying_shares":125400},"source":{"system":"sec-edgar","filing":"0001209191-22-021018","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875891/000120919122021018/doc4.xml","form_type":"4"}},{"id":2319039,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":79334,"kind":"person","name":"Hashim Mir","position":1,"cik":"0001875891","reported_name":"Hashim Mir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-24T21:06:41.000Z","date":"2022-03-22","kind":"grant","acquired":true,"shares":41200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"The shares subject to the restricted stock unit grant vest as follows: 25% of the RSUs shall vest yearly over four years from March 22, 2022."}],"balance_after":158800,"source":{"system":"sec-edgar","filing":"0001209191-22-021018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875891/000120919122021018/doc4.xml","form_type":"4"}},{"id":2572172,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":79334,"kind":"person","name":"Hashim Mir","position":1,"cik":"0001875891","reported_name":"Hashim Mir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-13T19:53:09.000Z","date":"2021-09-09","kind":"grant","acquired":true,"shares":117600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"The shares subject to the restricted stock unit grant vest as follows: 50% of the RSUs shall vest on September 9, 2022, and 50% shall vest on September 9, 2023."}],"balance_after":117600,"source":{"system":"sec-edgar","filing":"0001209191-21-055764","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875891/000120919121055764/doc4.xml","form_type":"4"}}]}